Author

Marina Zintchenko

University of FreiburgORCID 0000-0001-9717-0732Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Organism:human· 2 Assay:proteomics· 2 Approach:deep learning· 1 Approach:experimental assay· 1

Frequent Co-Authors

Susana MinguetiD· 2 shared Andreas ZinggiD· 1 shared Anna-Maria SchafferiD· 1 shared Anne HoltermanniD· 1 shared Azin Kiani· 1 shared Cabrera MaiaiD· 1 shared Christoph SchultheißiD· 1 shared David AnziD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Susana MinguetORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintDec 12, 2025

Controlling TCR and CAR activation by targeting LCK recruitment with a first-in-class small-molecule inhibitor

Nadine M. Woessner, Patricio Chinestrad, Tamina Rückert…·Susana Minguet

This study identifies a small-molecule inhibitor that selectively disrupts LCK recruitment to CD3ε, reducing TCR activation while preserving other immune responses.

1 citation

humanproteomics

𝕏 PostBluesky

Cancer BiologyNature CommunicationsPeer-reviewedFeb 2, 2024

Mutation-specific CAR T cells as precision therapy for IGLV3-21R110 expressing high-risk chronic lymphocytic leukemia

Florian Märkl, Christoph Schultheiß, Murtaza Ali…·Mascha Binder

This study develops CAR T cells targeting a specific mutation in CLL to selectively kill cancer cells while sparing healthy B cells.

15 citations

humanproteomics

𝕏 PostBluesky